Answers are grounded in this paper and cite their sources.
Increased IGF-1 might be an interesting serum marker for early PD and potentially for subclinical dopaminergic dysfunction.
No takes yet. Share an insight, caveat, or question.
Godau et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: